Novartis Finds Several Japan Trials Included An Employee's Involvement
This article was originally published in PharmAsia News
Executive Summary
More Japan clinical trials of Novartis Pharma's Valsartan (amlodipine) blood-pressure drug in Japan may be questioned in light of revelations an employee known to have been involved in one actually was involved in at least four.
You may also be interested in...
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.